Abiopharma

🔍 Rees Andrew (Director)

Company: Crocs, Inc. (CROX)

Report Date: 2026-06-05

Detailed Transactions and Holdings:

• Sold 6,900 shares of Common Stock at $116.9702 per share (Direct)
  Date: 2026-06-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 769,081.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 15,800 shares of Common Stock at $117.9443 per share (Direct)
  Date: 2026-06-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 753,281.00 | transaction_form_type: 4 | Footnotes: F3, F2
• Sold 9,988 shares of Common Stock at $119.1099 per share (Direct)
  Date: 2026-06-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 743,293.00 | transaction_form_type: 4 | Footnotes: F4, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-06-05 | Code: H | shares_owned_after: 475,789.00

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $116.55 - $117.54, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes.
• F2: The reporting person is a trustee of the REES FAMILY LIVING TRUST U/A DTD 03/22/2019 and exercises voting and investment power for the shares beneficially owned by the trust.
• F3: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $117.55 to $118.54, inclusive.
• F4: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $118.59 to $119.48, inclusive.